SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort.
Finch E, Lowe R, Fischinger S, de St Aubin M, Siddiqui SM, Dayal D, Loesche MA, Rhee J, Beger S, Hu Y, Gluck MJ, Mormann B, Hasdianda MA, Musk ER, Alter G, Menon AS, Nilles EJ, Kucharski AJ; CMMID COVID-19 working group and the SpaceX COVID-19 Cohort Collaborative.
Finch E, et al. Among authors: loesche ma.
PLoS Biol. 2022 Feb 10;20(2):e3001531. doi: 10.1371/journal.pbio.3001531. eCollection 2022 Feb.
PLoS Biol. 2022.
PMID: 35143473
Free PMC article.